Review: Intravenous Immunoglobulin and B Cells: When the Product Regulates the Producer

Publisher： John Wiley & Sons Inc

E-ISSN： 2326-5205|67|3|595-603

ISSN： 2326-5191

Source： ARTHRITIS & RHEUMATOLOGY, Vol.67, Iss.3, 2015-03, pp. : 595-603

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Specifications for anti‐A and anti‐B in intravenous immunoglobulin: history and rationale

By  

TRANSFUSION, Vol. 55, Iss. S2, 2015-07 ,pp. : S80-S85

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intravenous immunoglobulin as adjunct therapy for refractory pyoderma gangrenosum: systematic review of cases and case series

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 2, 2018-02 ,pp. : e164-e164

John Wiley & Sons Inc

Access to resources Recommend Favorite

Possible mechanisms for intravenous immunoglobulin–associated hemolysis: clues obtained from review of clinical case reports

By  

TRANSFUSION, Vol. 55, Iss. S2, 2015-07 ,pp. : S59-S64

John Wiley & Sons Inc

Access to resources Recommend Favorite

Incidence and natural history of intravenous immunoglobulin–induced aseptic meningitis: a retrospective review at a single tertiary care center

By  

TRANSFUSION, Vol. 55, Iss. 11, 2015-11 ,pp. : 2597-2605

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intravenous immunoglobulin as adjunct therapy for refractory pyoderma gangrenosum: systematic review of cases and case series

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 2, 2018-02 ,pp. : 363-368

John Wiley & Sons Inc

Access to resources Recommend Favorite